PHAR News and Press, Pharming Group N.V. From 06/01/23

2023-06-01 10:44:12 ET Pharming Group ( NASDAQ: PHAR ) has entered into a definitive agreement with Novartis Pharma A.G. to sell its Rare Pediatric Disease Priority Review Voucher, the company said Thursday. Under sale terms, Novartis has pre-agreed to a one-time payment...

Pharming announces sale of priority review voucher PR Newswire LEIDEN, The Netherlands , June 1, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that it has entered into a definitive agreem...

Pharming Group to attend the following Investor Conferences in June PR Newswire LEIDEN, The Netherlands , May 25, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management will attend the f...

2023-05-11 14:44:06 ET Pharming Group N.V. (PHGUF) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Sijmen de Vries – Chief Executive Officer Anurag Relan – Chief Medical Officer Stephen Toor – Chief Commercial Of...

2023-05-11 11:59:17 ET Pharming press release ( NASDAQ: PHAR ): Q1 GAAP EPS of -$0.017. Revenue of $42.54M (-8.8% Y/Y). For further details see: Pharming GAAP EPS of -$0.01, revenue of $42.54M

Pharming Group reports financial results for the first quarter of 2023 PR Newswire FDA approval and commercial launch of Joenja® (leniolisib) in the U.S. Joenja® launch off to strong start with 23 U.S. patients on paid therapy Revenues decreased by ...

2023-04-17 12:50:43 ET Summary Pharming Group N.V. is a Dutch company with two products in the market. However, despite having one product for 8 years now, the company has not managed to get its cash flow in order. Pharming Group N.V. trading volume is too low for investing. ...

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S. Canada NewsWire LEIDEN, Netherlands , April 11, 2023 /CNW/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the first co...

Pharming to present at the Guggenheim Healthcare Talks - Genomic Medicines and Rare Disease Days PR Newswire LEIDEN, The Netherlands , March 30, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming...

2023-03-27 13:06:40 ET Gainers: WiSA Technologies ( WISA ) +93% . First Citizens BancShares ( FCNCA ) +50% . Alimera Sciences ( ALIM ) +38% . Cimpress ( CMPR ) +30% . Gorilla Technology Group ( GRRR ) +25% . CBL International...